Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 10;15(1):12.
doi: 10.1186/s40246-021-00310-x.

The Human Genome Organisation (HUGO) and the 2020 COVID-19 pandemic

Benjamin Capps  1 , Yann Joly  2 , John Mulvihill  3 , Won Bok Lee  4 ; HUGO Committee on Ethics, Law and Society, and the HUGO Council
Affiliations

The Human Genome Organisation (HUGO) and the 2020 COVID-19 pandemic

Benjamin Capps et al. Hum Genomics. .

Abstract

This letter is the Human Genome Organisation's summary reaction to the 2020 COVID-19 pandemic. It identifies key areas for genomics research, and areas in which genomic scientists can contribute to a global response to the pandemic. The letter has been reviewed and endorsed by the HUGO Committee on Ethics, Law and Society (CELS) and the HUGO Council.

Keywords: COVID-19; Genomics; Human Genome Organisation; Public health pathogen genomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Seshaiyer P, McNeely C. Challenges and opportunities from COVID-19 for global sustainable development. World Med Health Policy. 2020;12:443–453. doi: 10.1002/wmh3.380. - DOI - PMC - PubMed
    1. OECD. The Territorial Impacts of COVID-19: Managing the Crisis Across Levels of Government. 2020. oecd.org/coronavirus. Available at: http://www.oecd.org/coronavirus/policy-responses/the-territorial-impact-...
    1. Atehortua N, Patino S. COVID-19, A tale of two pandemics: novel coronavirus and fake news messaging. Health Promot Int. 2021. 10.1093/heapro/daaa140. - PMC - PubMed
    1. Broughton J, Deng X, Yu G, et al. CRISPR–Cas12-based Detection of SARS-CoV-2. Nat Biotechnol. 2020;38:870–874. doi: 10.1038/s41587-020-0513-4. - DOI - PMC - PubMed
    1. Abbott T, Dhamdhere G, Liu Y, et al. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell. 2020;181:865–876. doi: 10.1016/j.cell.2020.04.020. - DOI - PMC - PubMed